201 related articles for article (PubMed ID: 16947022)
1. Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells.
Haque A; Das A; Hajiaghamohseni LM; Younger A; Banik NL; Ray SK
Cancer Immunol Immunother; 2007 May; 56(5):615-25. PubMed ID: 16947022
[TBL] [Abstract][Full Text] [Related]
2. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells.
Zhang R; Banik NL; Ray SK
Cancer Chemother Pharmacol; 2008 Aug; 62(3):407-16. PubMed ID: 17960384
[TBL] [Abstract][Full Text] [Related]
3. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.
Zhang R; Banik NL; Ray SK
Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of the combination of retinoid and interferon-gamma for inducing differentiation and increasing apoptosis in human glioblastoma T98G and U87MG cells.
Das A; Banik NL; Ray SK
Neurochem Res; 2009 Jan; 34(1):87-101. PubMed ID: 18368485
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.
Haque A; Banik NL; Ray SK
Neurochem Res; 2007 Dec; 32(12):2203-9. PubMed ID: 17676389
[TBL] [Abstract][Full Text] [Related]
6. Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells.
Das A; Banik NL; Ray SK
J Neurooncol; 2008 Mar; 87(1):9-22. PubMed ID: 17987264
[TBL] [Abstract][Full Text] [Related]
7. Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice.
Karmakar S; Banik NL; Ray SK
Cancer; 2008 Feb; 112(3):596-607. PubMed ID: 18098270
[TBL] [Abstract][Full Text] [Related]
8. Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis.
Das A; Banik NL; Ray SK
Neurochem Res; 2007 Dec; 32(12):2167-83. PubMed ID: 17694433
[TBL] [Abstract][Full Text] [Related]
9. Activation of Multiple Molecular Mechanisms for Increasing Apoptosis in Human Glioblastoma T98G Xenograft.
Karmakar S; Choudhury SR; Banik NL; Ray SK
J Cancer Sci Ther; 2010 Jun; 2():107-113. PubMed ID: 21666767
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.
Wastowski IJ; Simões RT; Yaghi L; Donadi EA; Pancoto JT; Poras I; Lechapt-Zalcman E; Bernaudin M; Valable S; Carlotti CG; Flajollet S; Jensen SS; Ferrone S; Carosella ED; Kristensen BW; Moreau P
Am J Pathol; 2013 Feb; 182(2):540-52. PubMed ID: 23219427
[TBL] [Abstract][Full Text] [Related]
11. Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice.
Karmakar S; Banik NL; Patel SJ; Ray SK
Apoptosis; 2007 Nov; 12(11):2077-87. PubMed ID: 17701358
[TBL] [Abstract][Full Text] [Related]
12. Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.
Darley R; Morris A; Passas J; Bateman W
Cancer Immunol Immunother; 1993 Jul; 37(2):112-8. PubMed ID: 8100485
[TBL] [Abstract][Full Text] [Related]
13. Effects of retinoic acid combined with interferon-gamma on the expression of major-histocompatibility-complex molecules and intercellular adhesion molecule-1 in human cervical cancer.
Santin AD; Hermonat P; Ravaggi A; Chiriva-Internati M; Hiserodt JC; Tian E; Carter CA; Pecorelli S; Parham GP
Int J Cancer; 1998 Jan; 75(2):254-8. PubMed ID: 9462716
[TBL] [Abstract][Full Text] [Related]
14. N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells.
Das A; Banik NL; Ray SK
Brain Res; 2008 Aug; 1227():207-15. PubMed ID: 18602901
[TBL] [Abstract][Full Text] [Related]
15. CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens.
Forlani G; Michaux J; Pak H; Huber F; Marie Joseph EL; Ramia E; Stevenson BJ; Linnebacher M; Accolla RS; Bassani-Sternberg M
Mol Cell Proteomics; 2021; 20():100032. PubMed ID: 33592498
[TBL] [Abstract][Full Text] [Related]
16. Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.
Zang C; Wächter M; Liu H; Posch MG; Fenner MH; Stadelmann C; von Deimling A; Possinger K; Black KL; Koeffler HP; Elstner E
J Neurooncol; 2003 Nov; 65(2):107-18. PubMed ID: 14686729
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of HLA-II related to LAG-3
Guo W; Peng D; Liao Y; Lou L; Guo M; Li C; Yu W; Tian X; Wang G; Lv P; Zuo J; Shen H; Li Y
Cancer Sci; 2024 May; 115(5):1388-1404. PubMed ID: 38480275
[TBL] [Abstract][Full Text] [Related]
18. Combined stimulation with interferon alpha and retinoic acid synergistically inhibits proliferation of the glioblastoma cell line GB12.
Ohno S; Nishi T; Kojima Y; Haraoka J; Ito H; Mizuguchi J
Neurol Res; 2002 Oct; 24(7):697-704. PubMed ID: 12392208
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D3 reduces the apoptotic effect of IFN-gamma but does not facilitate HLA class II inducibility in RB-defective cells.
Schmidt B; Carter SS; Berry DE; Blanck G
Cancer Lett; 1996 Dec; 110(1-2):169-76. PubMed ID: 9018097
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.
Yoshino A; Katayama Y; Yokoyama T; Watanabe T; Ogino A; Ota T; Komine C; Fukushima T; Kusama K
J Neurooncol; 2005 Sep; 74(3):249-60. PubMed ID: 16187022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
